Bank of New York Mellon’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Buy |
+49,898
| New | +$2.43M | ﹤0.01% | 2642 |
|
|
2024
Q1 | – | Sell |
-6,327
| Closed | -$100K | – | 4173 |
|
|
2023
Q4 | $100K | Buy |
6,327
+2,300
| +57% | +$36.5K | ﹤0.01% | 4076 |
|
|
2023
Q3 | $75.9K | Sell |
4,027
-36
| -0.9% | -$678 | ﹤0.01% | 4112 |
|
|
2023
Q2 | $91.8K | Buy |
4,063
+352
| +9% | +$7.96K | ﹤0.01% | 4086 |
|
|
2023
Q1 | $94.2K | Buy |
+3,711
| New | +$94.2K | ﹤0.01% | 4081 |
|
|
2021
Q2 | – | Sell |
-4,014
| Closed | -$214K | – | 4395 |
|
|
2021
Q1 | $214K | Buy |
4,014
+74
| +2% | +$3.95K | ﹤0.01% | 4026 |
|
|
2020
Q4 | $158K | Sell |
3,940
-203
| -5% | -$8.14K | ﹤0.01% | 4021 |
|
|
2020
Q3 | $236K | Sell |
4,143
-29
| -0.7% | -$1.65K | ﹤0.01% | 3790 |
|
|
2020
Q2 | $308K | Buy |
+4,172
| New | +$308K | ﹤0.01% | 3684 |
|
|
2019
Q2 | – | Sell |
-996
| Closed | -$53K | – | 4211 |
|
|
2019
Q1 | $53K | Buy |
+996
| New | +$53K | ﹤0.01% | 4076 |
|
|
2017
Q2 | – | Sell |
-2,118
| Closed | -$330K | – | 4302 |
|
|
2017
Q1 | $330K | Buy |
2,118
+133
| +7% | +$20.7K | ﹤0.01% | 3718 |
|
|
2016
Q4 | $413K | Buy |
1,985
+676
| +52% | +$141K | ﹤0.01% | 3667 |
|
|
2016
Q3 | $300K | Sell |
1,309
-45
| -3% | -$10.3K | ﹤0.01% | 3759 |
|
|
2016
Q2 | $279K | Buy |
1,354
+533
| +65% | +$110K | ﹤0.01% | 3767 |
|
|
2016
Q1 | $208K | Buy |
821
+4
| +0.5% | +$1.01K | ﹤0.01% | 3773 |
|
|
2015
Q4 | $280K | Buy |
817
+91
| +13% | +$31.2K | ﹤0.01% | 3738 |
|
|
2015
Q3 | $184K | Buy |
726
+116
| +19% | +$29.4K | ﹤0.01% | 3891 |
|
|
2015
Q2 | $171K | Buy |
+610
| New | +$171K | ﹤0.01% | 3921 |
|